What is antimicrobial resistance?

The core idea

Antimicrobial resistance (AMR) means that bacteria, viruses, fungi or parasites have changed so that the medicines used against them stop working well. Infections caused by resistant organisms are harder to treat: they last longer, spread more easily, need stronger or later-line drugs, and carry higher risks of severe illness and death.

Resistance is a property of the microbe, not of the patient: a person does not become immune to antibiotics, the bacteria do.

How resistance emerges

Microbes reproduce fast and swap genetic material, so any use of an antimicrobial selects for the rare organisms that survive it. The misuse and overuse of antimicrobials in humans, animals and agriculture is the main driver, made worse by poor infection prevention, lack of clean water and sanitation, and weak access to quality, affordable medicines and diagnostics.

Why it is a public-health problem

AMR spreads between people, animals and the environment, so one country's prescribing habits affect everyone. AMR ranks among the top global public-health threats: it makes routine surgery, childbirth, cancer chemotherapy and care of premature babies riskier, because all of these depend on reliable anti-infective drugs.

Tracking resistance patterns over time and place - surveillance - is what lets guidelines recommend the right first-choice drug in each region.

What slows it down

The levers with evidence behind them: use antibiotics only when they are actually indicated and at the right drug, dose and duration (antimicrobial stewardship); prevent infections in the first place through vaccination, hand hygiene and safe water; and keep developing new agents and diagnostics. For an individual, the practical rule is simple: never pressure a clinician for antibiotics for a viral illness, and complete a prescribed course as directed.